{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:24:23Z","timestamp":1792790663829,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["336825, 338507, 352795"],"award-info":[{"award-number":["336825, 338507, 352795"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["8047"],"award-info":[{"award-number":["8047"]}],"id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003756","name":"Biomedicum Helsinki-s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003756","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Doctoral School of University of Helsinki","id":[{"id":"https:\/\/ror.org\/040af2s02","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Migraine is a highly prevalent neurovascular disorder for which genome-wide association studies (GWAS) have identified over one hundred risk loci, yet the causal variants and genes remain mostly unknown. Here, we meta-analyze three migraine GWAS including 98,374 cases and 869,160 controls and identify 122 independent risk loci of which 35 were new. Fine-mapping of a meta-analysis is challenging because some variants may be missing from some participating studies and accurate linkage disequilibrium (LD) information of the variants is often not available. Here, using the exact in-sample LD, we first investigate which statistics could reliably capture the quality of fine-mapping when only reference LD is available. We observe that the posterior expected number of causal variants best distinguishes between the high- and low-quality results. Next, we perform fine-mapping for 102 autosomal risk regions using FINEMAP. We produce high-quality fine-mapping for 93 regions and define 181 distinct credible sets. Among the high-quality credible sets are 7 variants with very high posterior inclusion probability (PIP\u2009&gt;\u20090.9) and 2 missense variants with PIP\u2009&gt;\u20090.5 (rs6330 in\n                    <jats:italic>NGF<\/jats:italic>\n                    and rs1133400 in\n                    <jats:italic>INPP5A<\/jats:italic>\n                    ). For 35 association signals, we manage to narrow down the set of potential risk variants to at most 5 variants.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-64880-3","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T12:48:28Z","timestamp":1768222108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fine-mapping a genome-wide meta-analysis of 98,374 migraine cases identifies 181 sets of candidate causal variants"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5585-6856","authenticated-orcid":false,"given":"Heidi","family":"Hautakangas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1248-8782","authenticated-orcid":false,"given":"Joonas","family":"Kartau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"FinnGen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2527-5874","authenticated-orcid":false,"given":"Aarno","family":"Palotie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1664-1350","authenticated-orcid":false,"given":"Matti","family":"Pirinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"International Headache Genetics Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"64880_CR1","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38, 1\u2013211 (2018).","DOI":"10.1177\/0333102417738202"},{"key":"64880_CR2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos, T. et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204\u20131222 (2020).","journal-title":"Lancet"},{"key":"64880_CR3","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1212\/WNL.53.5.995","volume":"53","author":"M Gervil","year":"1999","unstructured":"Gervil, M., Ulrich, V., Kaprio, J., Olesen, J. & Russell, M. B. The relative role of genetic and environmental factors in migraine without aura. Neurology 53, 995\u2013999 (1999).","journal-title":"Neurology"},{"key":"64880_CR4","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/ng.652","volume":"42","author":"V Anttila","year":"2010","unstructured":"Anttila, V. et al. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat. Genet. 42, 869\u2013873 (2010).","journal-title":"Nat. Genet."},{"key":"64880_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/ng.856","volume":"43","author":"DI Chasman","year":"2011","unstructured":"Chasman, D. I. et al. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat. Genet. 43, 695\u2013U116 (2011).","journal-title":"Nat. Genet."},{"key":"64880_CR6","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ng.2307","volume":"44","author":"T Freilinger","year":"2012","unstructured":"Freilinger, T. et al. Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat. Genet. 44, 777\u2013782 (2012).","journal-title":"Nat. Genet."},{"key":"64880_CR7","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/ng.2676","volume":"45","author":"V Anttila","year":"2013","unstructured":"Anttila, V. et al. Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat. Genet. 45, 912\u2013U255 (2013).","journal-title":"Nat. Genet."},{"key":"64880_CR8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/ng.3570","volume":"48","author":"JK Pickrell","year":"2016","unstructured":"Pickrell, J. K. et al. Detection and interpretation of shared genetic influences on 42 human traits. Nat. Genet. 48, 709\u2013717 (2016).","journal-title":"Nat. Genet."},{"key":"64880_CR9","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3598","volume":"48","author":"P Gormley","year":"2016","unstructured":"Gormley, P. et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat. Genet. 48, 856\u2013866 (2016).","journal-title":"Nat. Genet."},{"key":"64880_CR10","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1177\/0333102417695105","volume":"38","author":"S-P Chen","year":"2018","unstructured":"Chen, S.-P. et al. Genome-wide association study identifies novel susceptibility loci for migraine in Han Chinese resided in Taiwan. Cephalalgia 38, 466\u2013475 (2018).","journal-title":"Cephalalgia"},{"key":"64880_CR11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/jmedgenet-2018-105359","volume":"55","author":"X Chang","year":"2018","unstructured":"Chang, X. et al. Common variants at 5q33.1 predispose to migraine in African-American children. J. Med. Genet. 55, 831 (2018).","journal-title":"J. Med. Genet."},{"key":"64880_CR12","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s42003-021-02356-y","volume":"4","author":"H Choquet","year":"2021","unstructured":"Choquet, H. et al. New and sex-specific migraine susceptibility loci identified from a multiethnic genome-wide meta-analysis. Commun. Biol. 4, 864 (2021).","journal-title":"Commun. Biol."},{"key":"64880_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41588-021-00990-0","volume":"54","author":"H Hautakangas","year":"2022","unstructured":"Hautakangas, H. et al. Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles. Nat. Genet. 54, 152\u2013160 (2022).","journal-title":"Nat. Genet."},{"key":"64880_CR14","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1038\/s41588-023-01538-0","volume":"55","author":"G Bjornsdottir","year":"2023","unstructured":"Bjornsdottir, G. et al. Rare variants with large effects provide functional insights into the pathology of migraine subtypes, with and without aura. Nat. Genet. 55, 1843\u20131853 (2023).","journal-title":"Nat. Genet."},{"key":"64880_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41588-018-0081-4","volume":"50","author":"HK Finucane","year":"2018","unstructured":"Finucane, H. K. et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat. Genet. 50, 621\u2013629 (2018).","journal-title":"Nat. Genet."},{"key":"64880_CR16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41576-018-0016-z","volume":"19","author":"DJ Schaid","year":"2018","unstructured":"Schaid, D. J., Chen, W. & Larson, N. B. From genome-wide associations to candidate causal variants by statistical fine-mapping. Nat. Rev. Genet. 19, 491\u2013504 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"64880_CR17","doi-asserted-by":"publisher","first-page":"e1004722","DOI":"10.1371\/journal.pgen.1004722","volume":"10","author":"G Kichaev","year":"2014","unstructured":"Kichaev, G. et al. Integrating functional data to prioritize causal variants in statistical fine-mapping studies. PLoS Genet. 10, e1004722 (2014).","journal-title":"PLoS Genet."},{"key":"64880_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1534\/genetics.114.167908","volume":"198","author":"F Hormozdiari","year":"2014","unstructured":"Hormozdiari, F., Kostem, E., Kang, E. Y., Pasaniuc, B. & Eskin, E. Identifying causal variants at loci with multiple signals of association. Genetics 198, 497\u2013508 (2014).","journal-title":"Genetics"},{"key":"64880_CR19","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/bioinformatics\/btw018","volume":"32","author":"C Benner","year":"2016","unstructured":"Benner, C. et al. FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics 32, 1493\u20131501 (2016).","journal-title":"Bioinformatics"},{"key":"64880_CR20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/gepi.21953","volume":"40","author":"PJ Newcombe","year":"2016","unstructured":"Newcombe, P. J., Conti, D. V. & Richardson, S. JAM: A Scalable Bayesian Framework for Joint Analysis of Marginal SNP Effects. Genet. Epidemiol. 40, 188\u2013201 (2016).","journal-title":"Genet. Epidemiol."},{"key":"64880_CR21","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/rssb.12388","volume":"82","author":"G Wang","year":"2020","unstructured":"Wang, G., Sarkar, A., Carbonetto, P. & Stephens, M. A simple new approach to variable selection in regression, with application to genetic fine mapping. J. R. Stat. Soc. Ser. B: Stat. Methodol. 82, 1273\u20131300 (2020).","journal-title":"J. R. Stat. Soc. Ser. B: Stat. Methodol."},{"key":"64880_CR22","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ajhg.2017.08.012","volume":"101","author":"C Benner","year":"2017","unstructured":"Benner, C. et al. Prospects of fine-mapping trait-associated genomic regions by using summary statistics from genome-wide association studies. Am. J. Hum. Genet. 101, 539\u2013551 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"64880_CR23","doi-asserted-by":"crossref","unstructured":"Kanai, M. et al. Meta-analysis fine-mapping is often miscalibrated at single-variant resolution. Cell Genomics 2, 100210 (2022).","DOI":"10.1101\/2022.03.16.22272457"},{"key":"64880_CR24","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","volume":"604","author":"V Trubetskoy","year":"2022","unstructured":"Trubetskoy, V. et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature 604, 502\u2013508 (2022).","journal-title":"Nature"},{"key":"64880_CR25","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ng.3406","volume":"47","author":"B Bulik-Sullivan","year":"2015","unstructured":"Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236\u20131241 (2015).","journal-title":"Nat. Genet."},{"key":"64880_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/gepi.22523","volume":"47","author":"M Isgut","year":"2023","unstructured":"Isgut, M., Song, K., Ehm, M. G., Wang, M. D. & Davitte, J. Effect of case and control definitions on genome-wide association study (GWAS) findings. Genet. Epidemiol. 47, 394\u2013406 (2023).","journal-title":"Genet. Epidemiol."},{"key":"64880_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ng.3211","volume":"47","author":"B Bulik-Sullivan","year":"2015","unstructured":"Bulik-Sullivan, B. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291\u2013295 (2015).","journal-title":"Nat. Genet."},{"key":"64880_CR28","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41588-021-00870-7","volume":"53","author":"J Mbatchou","year":"2021","unstructured":"Mbatchou, J. et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat. Genet. 53, 1097\u20131103 (2021).","journal-title":"Nat. Genet."},{"key":"64880_CR29","doi-asserted-by":"crossref","unstructured":"Meyers, T. J. et al. Transcriptome-wide association study identifies novel candidate susceptibility genes for migraine. HGG Adv 4, 100211 (2023).","DOI":"10.1016\/j.xhgg.2023.100211"},{"key":"64880_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/brain\/awab267","volume":"145","author":"S Bahrami","year":"2021","unstructured":"Bahrami, S. et al. Dissecting the shared genetic basis of migraine and mental disorders using novel statistical tools. Brain 145, 142\u2013153 (2021).","journal-title":"Brain"},{"key":"64880_CR31","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/ije\/dys095","volume":"42","author":"S Krokstad","year":"2012","unstructured":"Krokstad, S. et al. Cohort Profile: The HUNT Study, Norway. Int. J. Epidemiol. 42, 968\u2013977 (2012).","journal-title":"Int. J. Epidemiol."},{"key":"64880_CR32","doi-asserted-by":"publisher","first-page":"e1010299","DOI":"10.1371\/journal.pgen.1010299","volume":"18","author":"Y Zou","year":"2022","unstructured":"Zou, Y., Carbonetto, P., Wang, G. & Stephens, M. Fine-mapping from summary data with the \u201cSum of Single Effects\u201d model. PLOS Genet. 18, e1010299 (2022).","journal-title":"PLOS Genet."},{"key":"64880_CR33","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10048-015-0450-4","volume":"16","author":"AW Yang","year":"2015","unstructured":"Yang, A. W., Sachs, A. J. & Nystuen, A. M. Deletion of Inpp5a causes ataxia and cerebellar degeneration in mice. Neurogenetics 16, 277\u2013285 (2015).","journal-title":"Neurogenetics"},{"key":"64880_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14931-8","volume":"11","author":"Q Liu","year":"2020","unstructured":"Liu, Q. et al. Cerebellum-enriched protein INPP5A contributes to selective neuropathology in mouse model of spinocerebellar ataxias type 17. Nat. Commun. 11, 1101 (2020).","journal-title":"Nat. Commun."},{"key":"64880_CR35","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1373\/clinchem.2007.102798","volume":"54","author":"M Zorzetto","year":"2008","unstructured":"Zorzetto, M. et al. SERPINA1 Gene Variants in Individuals from the General Population with Reduced \u03b11-Antitrypsin Concentrations. Clin. Chem. 54, 1331\u20131338 (2008).","journal-title":"Clin. Chem."},{"key":"64880_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"64880_CR37","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.cell.2017.06.049","volume":"170","author":"RM Gupta","year":"2017","unstructured":"Gupta, R. M. et al. A Genetic Variant Associated with Five Vascular Diseases Is a Distal Regulator of Endothelin-1 Gene Expression. Cell 170, 522\u2013533.e15 (2017).","journal-title":"Cell"},{"key":"64880_CR38","first-page":"e002327","volume":"11","author":"X Wang","year":"2018","unstructured":"Wang, X. & Musunuru, K. Confirmation of Causal rs9349379-PHACTR1 Expression Quantitative Trait Locus in Human-Induced Pluripotent Stem Cell Endothelial Cells. Circulation: Genom. Precis. Med. 11, e002327 (2018).","journal-title":"Circulation: Genom. Precis. Med."},{"key":"64880_CR39","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.ajhg.2016.06.034","volume":"99","author":"D-C Guo","year":"2016","unstructured":"Guo, D.-C et al. Genetic Variants in LRP1 and ULK4 Are Associated with Acute Aortic Dissections. Am. J. Hum. Genet. 99, 762\u2013769 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"64880_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26174-2","volume":"12","author":"A Georges","year":"2021","unstructured":"Georges, A. et al. Genetic investigation of fibromuscular dysplasia identifies risk loci and shared genetics with common cardiovascular diseases. Nat. Commun. 12, 6031 (2021).","journal-title":"Nat. Commun."},{"key":"64880_CR41","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/jamacardio.2020.0872","volume":"5","author":"TN Turley","year":"2020","unstructured":"Turley, T. N. et al. Identification of Susceptibility Loci for Spontaneous Coronary Artery Dissection. JAMA Cardiol. 5, 929\u2013938 (2020).","journal-title":"JAMA Cardiol."},{"key":"64880_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-021-00260-5","volume":"18","author":"SE Storck","year":"2021","unstructured":"Storck, S. E., Kurtyka, M. & Pietrzik, C. U. Brain endothelial LRP1 maintains blood\u2013brain barrier integrity. Fluids Barriers CNS 18, 27 (2021).","journal-title":"Fluids Barriers CNS"},{"key":"64880_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s40139-022-00231-x","volume":"10","author":"Z Liu","year":"2022","unstructured":"Liu, Z., Andraska, E., Akinbode, D., Mars, W. & Alvidrez, R. I. M. LRP1 in the Vascular Wall. Curr. Pathobiol. Rep. 10, 23\u201334 (2022).","journal-title":"Curr. Pathobiol. Rep."},{"key":"64880_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44319-3","volume":"14","author":"J Lee","year":"2023","unstructured":"Lee, J. et al. ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells. Nat. Commun. 14, 8463 (2023).","journal-title":"Nat. Commun."},{"key":"64880_CR45","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1161\/CIRCRESAHA.124.325269","volume":"135","author":"L Liu","year":"2024","unstructured":"Liu, L. et al. LRP1 Repression by SNAIL Results in ECM Remodeling in Genetic Risk for Vascular Diseases. Circulation Res. 135, 1084\u20131097 (2024).","journal-title":"Circulation Res."},{"key":"64880_CR46","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/j.1460-2075.1985.tb03791.x","volume":"4","author":"S Korsching","year":"1985","unstructured":"Korsching, S., Auburger, G., Heumann, R., Scott, J. & Thoenen, H. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J. 4, 1389\u20131393 (1985).","journal-title":"EMBO J."},{"key":"64880_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-0173(98)00004-6","volume":"27","author":"B Connor","year":"1998","unstructured":"Connor, B. & Dragunow, M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Rev. 27, 1\u201339 (1998).","journal-title":"Brain Res. Rev."},{"key":"64880_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0333102415625614","volume":"37","author":"RM van Dongen","year":"2017","unstructured":"van Dongen, R. M. et al. Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis. Cephalalgia 37, 49\u201363 (2017).","journal-title":"Cephalalgia"},{"key":"64880_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01377-6","volume":"23","author":"M Mozafarihashjin","year":"2022","unstructured":"Mozafarihashjin, M. et al. Assessment of peripheral biomarkers potentially involved in episodic and chronic migraine: a case-control study with a focus on NGF, BDNF, VEGF, and PGE2. J. Headache Pain. 23, 3 (2022).","journal-title":"J. Headache Pain."},{"key":"64880_CR50","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/art.1780350315","volume":"35","author":"L Aloe","year":"1992","unstructured":"Aloe, L., Tuveri, M. A., Carcassi, U. & Levi-Montalcini, R. Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheumatism 35, 351\u2013355 (1992).","journal-title":"Arthritis Rheumatism"},{"key":"64880_CR51","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/path.1108","volume":"197","author":"AJ Freemont","year":"2002","unstructured":"Freemont, A. J. et al. Nerve growth factor expression and innervation of the painful intervertebral disc. J. Pathol. 197, 286\u2013292 (2002).","journal-title":"J. Pathol."},{"key":"64880_CR52","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1093\/rheumatology\/keq188","volume":"49","author":"DA Walsh","year":"2010","unstructured":"Walsh, D. A. et al. Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis. Rheumatol. (Oxf.) 49, 1852\u20131861 (2010).","journal-title":"Rheumatol. (Oxf.)"},{"key":"64880_CR53","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1016\/j.pain.2013.05.051","volume":"154","author":"P Sanga","year":"2013","unstructured":"Sanga, P. et al. Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain. Pain 154, 1910\u20131919 (2013).","journal-title":"Pain"},{"key":"64880_CR54","first-page":"523","volume":"7","author":"PJ Tiseo","year":"2014","unstructured":"Tiseo, P. J., Ren, H. & Mellis, S. Fasinumab (REGN475), an antinerve growth factor monoclonal antibody, for the treatment of acute sciatic pain: results of a proof-of-concept study. J. Pain. Res. 7, 523\u2013530 (2014).","journal-title":"J. Pain. Res."},{"key":"64880_CR55","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.joca.2019.05.029","volume":"27","author":"FE Watt","year":"2019","unstructured":"Watt, F. E. et al. Tropomyosin-related kinase A (TrkA) inhibition for the treatment of painful knee osteoarthritis: results from a randomized controlled phase 2a trial. Osteoarthr. Cartil. 27, 1590\u20131598 (2019).","journal-title":"Osteoarthr. Cartil."},{"key":"64880_CR56","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/annrheumdis-2019-216296","volume":"79","author":"F Berenbaum","year":"2020","unstructured":"Berenbaum, F. et al. Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period. Ann. Rheum. Dis. 79, 800\u2013810 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"64880_CR57","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41584-020-00528-4","volume":"17","author":"BL Wise","year":"2021","unstructured":"Wise, B. L., Seidel, M. F. & Lane, N. E. The evolution of nerve growth factor inhibition in clinical medicine. Nat. Rev. Rheumatol. 17, 34\u201346 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"64880_CR58","doi-asserted-by":"publisher","first-page":"2149055","DOI":"10.1080\/19420862.2022.2149055","volume":"15","author":"Y Koya","year":"2023","unstructured":"Koya, Y. et al. A novel anti-NGF PEGylated Fab\u2019 provides analgesia with lower risk of adverse effects. mAbs 15, 2149055 (2023).","journal-title":"mAbs"},{"key":"64880_CR59","doi-asserted-by":"publisher","first-page":"e2211","DOI":"10.1212\/WNL.0000000000006640","volume":"91","author":"HC Detke","year":"2018","unstructured":"Detke, H. C. et al. Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study. Neurology 91, e2211\u2013e2221 (2018).","journal-title":"Neurology"},{"key":"64880_CR60","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1177\/0333102418759786","volume":"38","author":"DW Dodick","year":"2018","unstructured":"Dodick, D. W. et al. ARISE: A Phase 3 randomized trial of erenumab for episodic migraine. Cephalalgia 38, 1026\u20131037 (2018).","journal-title":"Cephalalgia"},{"key":"64880_CR61","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(19)31946-4","volume":"394","author":"MD Ferrari","year":"2019","unstructured":"Ferrari, M. D. et al. Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial. Lancet 394, 1030\u20131040 (2019).","journal-title":"Lancet"},{"key":"64880_CR62","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0014-5793(94)00509-5","volume":"347","author":"F De Smedt","year":"1994","unstructured":"De Smedt, F., Verjans, B., Mailleux, P. & Erneux, C. Cloning and expression of human brain type I inositol 1,4,5-trisphosphate 5-phosphatase High levels of mRNA in cerebellar Purkinje cells. FEBS Lett. 347, 69\u201372 (1994).","journal-title":"FEBS Lett."},{"key":"64880_CR63","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1161\/ATVBAHA.122.317431","volume":"42","author":"S Rubin","year":"2022","unstructured":"Rubin, S. et al. PHACTR-1 (Phosphatase and actin regulator 1) deficiency in either endothelial or smooth muscle cells does not predispose mice to nonatherosclerotic arteriopathies in 3 transgenic mice. Arteriosclerosis, Thrombosis, Vasc. Biol. 42, 597\u2013609 (2022).","journal-title":"Arteriosclerosis, Thrombosis, Vasc. Biol."},{"key":"64880_CR64","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1093\/bioinformatics\/btu416","volume":"30","author":"B Pasaniuc","year":"2014","unstructured":"Pasaniuc, B. et al. Fast and accurate imputation of summary statistics enhances evidence of functional enrichment. Bioinformatics 30, 2906\u20132914 (2014).","journal-title":"Bioinformatics"},{"key":"64880_CR65","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1089\/cmb.2019.0449","volume":"27","author":"Y Wu","year":"2020","unstructured":"Wu, Y., Eskin, E. & Sankararaman, S. A unifying framework for imputing summary statistics in genome-wide association studies. J. Computational Biol. 27, 418\u2013428 (2020).","journal-title":"J. Computational Biol."},{"key":"64880_CR66","doi-asserted-by":"publisher","first-page":"i2610","DOI":"10.1136\/bmj.i2610","volume":"353","author":"T Kurth","year":"2016","unstructured":"Kurth, T. et al. Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ 353, i2610 (2016).","journal-title":"BMJ"},{"key":"64880_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42614-7","volume":"14","author":"M Cai","year":"2023","unstructured":"Cai, M. et al. XMAP: Cross-population fine-mapping by leveraging genetic diversity and accounting for confounding bias. Nat. Commun. 14, 6870 (2023).","journal-title":"Nat. Commun."},{"key":"64880_CR68","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"64880_CR69","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508\u2013518 (2023).","journal-title":"Nature"},{"key":"64880_CR70","doi-asserted-by":"publisher","first-page":"s13742","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience 4, s13742\u2013s13748 (2015).","journal-title":"GigaScience"},{"key":"64880_CR71","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","volume":"26","author":"A Manichaikul","year":"2010","unstructured":"Manichaikul, A. et al. Robust relationship inference in genome-wide association studies. Bioinformatics 26, 2867\u20132873 (2010).","journal-title":"Bioinformatics"},{"key":"64880_CR72","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gkj144","volume":"34","author":"AS Hinrichs","year":"2006","unstructured":"Hinrichs, A. S. et al. The UCSC genome browser database: update 2006. Nucleic Acids Res. 34, D590\u2013D598 (2006).","journal-title":"Nucleic Acids Res."},{"key":"64880_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-288","volume":"11","author":"R M\u00e4gi","year":"2010","unstructured":"M\u00e4gi, R. & Morris, A. P. GWAMA: software for genome-wide association meta-analysis. BMC Bioinforma. 11, 288 (2010).","journal-title":"BMC Bioinforma."},{"key":"64880_CR74","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ajhg.2011.02.002","volume":"88","author":"SH Lee","year":"2011","unstructured":"Lee, S. H., Wray, N. R., Goddard, M. E. & Visscher, P. M. Estimating missing heritability for disease from genome-wide association studies. Am. J. Hum. Genet. 88, 294\u2013305 (2011).","journal-title":"Am. J. Hum. Genet."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64880-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64880-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64880-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:10:54Z","timestamp":1768342254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64880-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["64880"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64880-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.P. is the Scientific Director of the public-private partnership project FinnGen that has 12 industry partners that provide funding for the FinnGen project. Other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"355"}}